Pasar al contenido principal

COSTE-UTILIDAD Y EFECTOS INMUNO-INFLAMATORIOS DE LA TERAPIA MULTICOMPONENTE FIBROWALK EN FORMATO ONLINE O AL AIRE LIBRE EN FIBROMIALGIA: UN ENSAYO CONTROLADO ALEATORIZADO

PID2020-117667RA-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Assessing the Impact of the Way of Saint James on Psychological Distress and Subjective Well-being, The Ultreya Study

  • Feliu-Soler, Albert|||0000-0003-2810-7670
  • Royuela-Colomer, Estíbaliz|||0000-0001-9912-9610
  • Navarrete Hidalgo, Jaime|||0000-0002-9482-4822
  • Jørgensen, Nanna Natalia
  • Mariño, Manu
  • Demarzo, Marcelo|||0000-0002-7447-1839
  • Soler, Joaquim|||0000-0001-8077-3641
  • Garcia-Campayo, Javier|||0000-0002-3797-4218
  • Montero-Marín, Jesús|||0000-0001-5677-1662
  • Luciano, Juan Vicente|||0000-0003-0750-1599
This study aimed to examine the impact of a pilgrimage on the Way of St. James on psychological distress and subjective well-being, and to compare these outcomes with a control group on non-pilgrimage vacations. Additionally, the study explored psychological process variables that may mediate the pilgrimage's beneficial effects. A nonrandomized pretest-posttest design was used, involving 444 pilgrims and 124 controls. Participants completed baseline and post-experience self-reported measures of psychological distress, subjective well-being, and psychological processes (i.e., mindfulness, nonattachment, engaged living). A 3-month follow-up was conducted only in the pilgrim group. Mediation analyses examined psychological processes as potential mediators of pre-post change in the pilgrim group (vs. control). Within-group analyses revealed that the pilgrim group experienced improvements in psychological distress, subjective well-being, and psychological processes immediately post-experience, with most measures sustaining improvement at the 3-month follow-up. Compared to the control group, pilgrims showed significantly greater increases in positive affect, life satisfaction, and valued living, alongside greater reductions in anxiety, depression, and perceived stress. Valued living partially mediated the relationship between pilgrimage and positive affect, and fully mediated the effects on perceived stress, negative affect, life satisfaction, and subjective happiness. Pilgrimage on the Way of St. James effectively reduced psychological distress and enhanced subjective well-being, with greater benefits observed compared to a non-pilgrimage vacation control group. Consistent with the concept of pilgrimage as a transformative experience, significant improvements in valued living were noted, which mediated some of the positive outcomes post-pilgrimage. The Way of St. James may serve as a valuable complementary approach for alleviating distress and promoting well-being. Further studies exploring the effects of this pilgrimage on specific populations and using more robust study designs are warranted. Trial Registration ClinicalTrials.gov Identifier NCT04141813.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Immune-inflammatory effects of the multicomponent intervention FIBROWALK in outdoor and online formats for patients with fibromyalgia

  • Ferrés, Sònia
  • Serrat, Mayte|||0000-0002-5591-9407
  • Auer, William|||0009-0004-1660-8106
  • Royuela-Colomer, Estíbaliz|||0000-0001-9912-9610
  • Almirall, Míriam|||0000-0002-4874-8013
  • Lizama-Lefno, Andrea
  • Nijs, Jo|||0000-0002-4976-6563
  • Maes, Michael|||0000-0002-2012-871X
  • Luciano, Juan Vicente|||0000-0003-0750-1599
  • Borràs, Xavier|||0000-0003-3972-1385
  • Feliu-Soler, Albert|||0000-0003-2810-7670
The multicomponent intervention FIBROWALK integrates pain science education (PSE), therapeutic exercise, cognitive behavioral therapy (CBT), and mindfulness training for treating fibromyalgia (FM). This study investigated the effects of the FIBROWALK in online (FIBRO-On) and outdoor (FIBRO-Out) formats compared to treatment-as-usual (TAU) on core clinical variables along with serum immune-inflammatory biomarkers and brain-derived neurotrophic factor (BDNF). Furthermore, the predictive value of these biomarkers on clinical response to FIBROWALK was also evaluated. 120 participants were randomly divided into three groups: TAU, TAU + FIBRO-On or TAU + FIBRO-Out. Clinical and blood assessments were conducted pre-post treatment. Both FIBRO-Out and FIBRO-On showed effectiveness (vs TAU) by improving functional impairment and kinesiophobia. Individuals allocated to FIBRO-Out (vs TAU) additionally showed decreases in pain, fatigue, depressive symptoms, and serum IL-6 and IL-10 levels along with IL-6/IL-4 ratio; patients allocated to FIBRO-On only showed a less stepped increase in IL-6 compared to TAU. An exaggerated pro-inflammatory profile along with higher levels of BDNF at baseline predicted greater clinical improvements in both active treatment arms. Our results suggest that FIBROWALK - in online and outdoor formats- is effective in individuals with FM and has significant immune regulatory effects in FM patients, while immune-inflammatory pathways and BDNF levels may in part predict its clinical effectiveness.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The Psychological Benefits of Forest Bathing in Individuals with Fibromyalgia and Chronic Fatigue Syndrome/Myalgic Encephalomyelitis, A Pilot Study

  • Serrat López, Mayte|||0000-0002-5591-9407
  • Royuela-Colomer, Estíbaliz|||0000-0001-9912-9610
  • Alonso Marsol, Sandra
  • Ferrés Puigdevall, Sònia|||0000-0001-5305-8386
  • Nieto Luna, Rubén|||0000-0002-8759-319X
  • Feliu-Soler, Albert|||0000-0003-2810-7670
  • Muro Rodríguez, Anna|||0000-0002-1331-9921
Background/Objectives: The main objective of the present study is to assess the short-term effects of Forest Bathing (FB) conducted in a Mediterranean forest on individuals with fibromyalgia (FM) and/or chronic fatigue syndrome/myalgia encephalomyelitis (CFS/ME) on perceived pain, fatigue, state anxiety, positive and negative affect, mood states, and state mindfulness. Methods: A total of 44 participants with FM and/or CSF/ME agreed to participate in this study. The FB session consisted of a 3 km silent walk, lasting three hours and guided by a specialized psychologist and a mountain guide to guarantee the safety of the activity. Paired-sample t-tests were used to analyze the pre-post changes in perceived pain, fatigue, state anxiety, positive and negative affect, mood states, and mindfulness. Results: All reported variables but self-reported pain showed statistically significant pre-post variations after the FB session. Particularly, large-to-very-large improvements in positive and negative affect, state anxiety, tension, depression, anger, and vigor were found. Small-to-moderate effect sizes for fatigue, friendliness, and state mindfulness were also reported. Conclusions: This study provides preliminary evidence of the short-term benefits of FB in individuals with FM and/or CFS/ME, especially on state anxiety and negative affect.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Economic evaluation of the FIBROWALK multicomponent intervention in online and outdoor formats for fibromyalgia (The On & Out Study)

  • Auer, William
  • Serrat López, Mayte|||0000-0002-5591-9407
  • Sanabria-Mazo, Juan P.|||0000-0003-1688-435X
  • Royuela-Colomer, Estíbaliz|||0000-0001-9912-9610
  • Pérez-Aranda, Adrián|||0000-0002-1602-3413
  • Ferrés Puigdevall, Sònia|||0000-0001-5305-8386
  • Robles, Brenda|||0000-0001-6023-7809
  • D'Amico, Francesco|||0000-0001-7995-826X
  • Almirall, Míriam|||0000-0002-4874-8013
  • Cardeñosa, Eugenia|||0000-0002-9735-2269
  • Borràs, Xavier|||0000-0003-3972-1385
  • Luciano, Juan Vicente|||0000-0003-0750-1599
  • Feliu-Soler, Albert|||0000-0003-2810-7670
Fibromyalgia (FM) is a chronic condition with substantial healthcare and societal costs. Although multicomponent interventions are widely available, evidence of their economic impact remains scarce. This study evaluated the cost-utility and cost-effectiveness of the FIBROWALK intervention in online (FIBRO-On) and outdoor (FIBRO-Out) formats, compared to treatment as usual (TAU), for individuals with FM. An economic evaluation (n = 225) was conducted over six months from government (total costs) and healthcare (direct costs) perspectives. The follow-up assessment was conducted six months after baseline, which corresponds to three months after the end of the 12-week intervention. Direct and indirect costs were collected through the Client Service Receipt Inventory. Cost-utility was assessed with Quality Adjusted Life Years (QALYs) and cost-effectiveness with the Revised Fibromyalgia Impact Questionnaire (FIQR). FIBRO-On was superior to TAU in reducing specialized healthcare costs (Cohen's d = 0.71), improving perceived health (d = 0.50), and reducing FM severity (d = 0.56). Compared to FIBRO-Out, FIBRO-On also reduced healthcare costs and improved both QALYs and FIQR scores. In contrast, FIBRO-Out led to significantly higher costs than TAU and showed no significant benefit in QALYs or FIQR scores. Across intentionto-treat, complete case, and per-protocol analyses, FIBRO-On was also the more favorable intervention, particularly in comparison to FIBRO-Out. These findings suggest that FIBROOn may be a cost-effective intervention for managing FM compared to TAU or FIBRO-Out. Furthermore, they underscore the potential benefits of exploring digital interventions such as FIBRO-On to improve accessibility and promote efficient use of healthcare resources to manage FM.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Effectiveness of the FIBROWALK multicomponent therapy in online and outdoor formats for fibromyalgia, a randomized controlled trial (The On & Out study)

  • Serrat López, Mayte|||0000-0002-5591-9407
  • Royuela-Colomer, Estíbaliz|||0000-0001-9912-9610
  • Auer, William
  • Ferrés Puigdevall, Sònia|||0000-0001-5305-8386
  • Almirall, Míriam|||0000-0002-4874-8013
  • Neblett, Randy|||0000-0002-8620-2468
  • Nijs, Jo|||0000-0002-4976-6563
  • Sanabria-Mazo, Juan P.|||0000-0003-1688-435X
  • Borràs, Xavier|||0000-0003-3972-1385
  • Luciano, Juan Vicente|||0000-0003-0750-1599
  • Feliu-Soler, Albert|||0000-0003-2810-7670
This study evaluated the effectiveness of FIBROWALK multicomponent intervention, delivered online (FIBRO-On) or outdoors (FIBRO-Out), compared to treatment as usual (TAU) in reducing fibromyalgia (FM) severity measured by FIQR, which assesses functional impairment, symptom intensity, and overall impact. A total of 225 individuals with FM were randomly assigned to 12 weeks of FIBRO-On (plus TAU), FIBRO-Out (plus TAU), or TAU alone. Assessments were conducted at baseline, mid-intervention (6 weeks), post-intervention (12 weeks), and 6-months (3 months post-intervention). Results from linear mixed-effects models indicated that FIBRO-On (ꞵ = -10.68, 95% CI = -15.13, -6.23) and FIBRO-Out (ꞵ = 9.91, 95% CI = -14.4, -5.42) were more effective than TAU in reducing FM severity at postintervention. FIBRO-On (ꞵ = -6.02, 95% CI = -10.78, -1.27) was more effective than TAU in reducing FM severity at 6 months, whereas FIBRO-Out showed no such advantage. No significant differences were observed between FIBRO-On and FIBRO-Out for any clinical measure at any time point. Clinically meaningful improvement was observed in 36.3% of FIBRO-On and 37.2% of FIBRO-Out post-intervention and ~20% at follow-up. Reductions in psychological inflexibility and kinesiophobia after the intervention mediated the effects of FIBROWALK on FM severity at 6-month follow-up, supporting the inclusion of acceptance and commitment therapy components in future versions. Low dropout rates, minimal adverse effects, and significant improvements across clinical outcomes highlight the feasibility and effectiveness of both formats. These findings support FIBROWALK, particularly FIBRO-On, as a scalable FM intervention. Future research should optimize long-term outcomes and explore personalized treatment delivery.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Predicting adherence and clinical response of cognitive behavioral therapy among individuals with chronic low back pain plus depressive symptoms, a secondary analysis of a randomized controlled trial

  • Sanabria-Mazo, Juan P.|||0000-0003-1688-435X
  • Royuela-Colomer, Estíbaliz|||0000-0001-9912-9610
  • Navarrete Hidalgo, Jaime|||0000-0002-9482-4822
  • Rodríguez Freire, Carla|||0009-0006-6728-5778
  • Robles, Brenda|||0000-0001-6023-7809
  • McCracken, Lance M.|||0000-0002-9734-0153
  • Feliu-Soler, Albert|||0000-0003-2810-7670
  • Luciano, Juan Vicente|||0000-0003-0750-1599
BACKGROUND: Identifying predictors for adherence and clinical response to psychological therapies is essential for improving individual treatment outcomes. OBJECTIVE: To explore predictors of adherence and clinical response among individuals with co-occurring chronic low back pain (CLBP) and depression receiving cognitive behavioral therapy (CBT). METHODS: This study employs a secondary analysis of data from a randomized controlled trial (NCT04140838), including 156 individuals with CLBP plus depressive symptoms who received CBT. Multiple linear regression analyses were conducted to assess the predictive power of sociodemographic, health status, pain-related, and therapy-related variables on adherence and clinical response. Adherence was measured by therapy progress (number of completed sessions) and therapy completion (attendance at least six out of eight sessions). Clinical response was assessed by a clinically relevant reduction in posttreatment pain interference. RESULTS: Older age, higher therapy credibility, and higher education level predicted greater therapy progress, while higher therapy credibility and lower baseline stress levels predicted greater therapy completion. In addition, higher opioid use, baseline pain interference, and baseline depression levels predicted lower clinical response; in contrast, higher behavioral activation levels, older age, and unemployment predicted higher clinical response. CONCLUSION: Therapy credibility, age, and education level are key predictors of adherence, and baseline levels of pain interference, depression, and behavioral activation are key predictors of clinical response. These findings may inform opportunities to develop more effective personalized therapeutic plans for individuals with CLBP and depression.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Assessing the Impact of the Way of Saint James on Psychological Distress and Subjective Well-being: The Ultreya Study

  • Feliu-Soler, A.
  • Royuela-Colomer, E.
  • Navarrete, J.
  • Jørgensen, N. N.
  • Mariño, M.
  • Demarzo, M.
  • Soler, J.
  • García-Campayo, J.
  • Montero-Marín, J.
  • Luciano, J. V.
This study aimed to examine the impact of a pilgrimage on the Way of St. James on psychological distress and subjective well-being, and to compare these outcomes with a control group on non-pilgrimage vacations. Additionally, the study explored psychological process variables that may mediate the pilgrimage's beneficial effects. A nonrandomized pretest-posttest design was used, involving 444 pilgrims and 124 controls. Participants completed baseline and post-experience self-reported measures of psychological distress, subjective well-being, and psychological processes (i.e., mindfulness, nonattachment, engaged living). A 3-month follow-up was conducted only in the pilgrim group. Mediation analyses examined psychological processes as potential mediators of pre-post change in the pilgrim group (vs. control). Within-group analyses revealed that the pilgrim group experienced improvements in psychological distress, subjective well-being, and psychological processes immediately post-experience, with most measures sustaining improvement at the 3-month follow-up. Compared to the control group, pilgrims showed significantly greater increases in positive affect, life satisfaction, and valued living, alongside greater reductions in anxiety, depression, and perceived stress. Valued living partially mediated the relationship between pilgrimage and positive affect, and fully mediated the effects on perceived stress, negative affect, life satisfaction, and subjective happiness. Pilgrimage on the Way of St. James effectively reduced psychological distress and enhanced subjective well-being, with greater benefits observed compared to a non-pilgrimage vacation control group. Consistent with the concept of pilgrimage as a transformative experience, significant improvements in valued living were noted, which mediated some of the positive outcomes post-pilgrimage. The Way of St. James may serve as a valuable complementary approach for alleviating distress and promoting well-being. Further studies exploring the effects of this pilgrimage on specific populations and using more robust study designs are warranted.Trial Registration ClinicalTrials.gov Identifier NCT04141813.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Effectiveness, cost-utility and physiological underpinnings of the FIBROWALK multicomponent therapy in online and outdoor format in individuals with fibromyalgia, Study protocol of a randomized, controlled trial (On&Out study)

  • Serrat López, Mayte|||0000-0002-5591-9407
  • Ferrés Puigdevall, Sònia|||0000-0001-5305-8386
  • Auer, William
  • Almirall, Míriam|||0000-0002-4874-8013
  • Lluch, Enrique|||0000-0003-4119-7551
  • D'Amico, Francesco|||0000-0001-7995-826X
  • Maes, Michael|||0000-0002-2012-871X
  • Lorente Sánchez, Sonia|||0000-0002-5494-3325
  • Navarrete Hidalgo, Jaime|||0000-0002-9482-4822
  • Montero-Marín, Jesús|||0000-0001-5677-1662
  • Neblett, Randy|||0000-0002-8620-2468
  • Nijs, Jo|||0000-0002-4976-6563
  • Borràs, Xavier|||0000-0003-3972-1385
  • Luciano, Juan Vicente|||0000-0003-0750-1599
  • Feliu-Soler, Albert|||0000-0003-2810-7670
Introduction: The On&Out study is aimed at assessing the effectiveness, cost-utility and physiological underpinnings of the FIBROWALK multicomponent intervention conducted in two different settings: online (FIBRO-On) or outdoors (FIBRO-Out). Both interventions have proved to be efficacious in the short-term but there is no study assessing their comparative effectiveness nor their long-term effects. For the first time, this study will also evaluate the cost-utility (6-month time-horizon) and the effects on immune-inflammatory biomarkers and Brain-Derived Neurotrophic Factor (BDNF) levels of both interventions. The objectives of this 6-month, randomized, controlled trial (RCT) are 1) to examine the effectiveness and cost-utility of adding FIBRO-On or FIBRO-Out to Treatment-As-Usual (TAU) for individuals with fibromyalgia (FM); 2) to identify pre-post differences in blood biomarker levels in the three study arms and 3) to analyze the role of process variables as mediators of 6-month follow-up clinical outcomes. Methods and analysis: Participants will be 225 individuals with FM recruited at Vall d'Hebron University Hospital (Barcelona, Spain), randomly allocated to one of the three study arms: TAU vs. TAU + FIBRO-On vs. TAU + FIBRO-Out. A comprehensive assessment to collect functional impairment, pain, fatigue, depressive and anxiety symptoms, perceived stress, central sensitization, physical function, sleep quality, perceived cognitive dysfunction, kinesiophobia, pain catastrophizing, psychological inflexibility in pain and pain knowledge will be conducted pre-intervention, at 6 weeks, post-intervention (12 weeks), and at 6-month follow-up. Changes in immune-inflammatory biomarkers [i.e., IL-6, CXCL8, IL-17A, IL-4, IL-10, and high-sensitivity C-reactive protein (hs-CRP)] and Brain-Derived Neurotrophic Factor will be evaluated in 40 participants in each treatment arm (total n = 120) at pre- and post-treatment. Quality of life and direct and indirect costs will be evaluated at baseline and at 6-month follow-up. Linear mixed-effects regression models using restricted maximum likelihood, mediational models and a full economic evaluation applying bootstrapping techniques, acceptability curves and sensitivity analyses will be computed. Ethics and dissemination: This study has been approved by the Ethics Committee of the Vall d'Hebron Institute of Research. The results will be actively disseminated through peer-reviewed journals, conference presentations, social media and various community engagement activities. Trial registration number NCT05377567 ().
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Combining mindfulness and cognitive training in children with attention deficit hyperactivity disorder, study protocol of a pilot randomized controlled trial (the NeuroMind study)

  • Badia Aguarón, Tania|||0000-0003-3131-9818
  • Royuela-Colomer, Estíbaliz|||0000-0001-9912-9610
  • Pera Guardiola, Vanessa
  • Vergés-Balasch, Pere
  • Cebolla Marti, Ausias|||0000-0002-3456-9743
  • Luciano, Juan Vicente|||0000-0003-0750-1599
  • Soler, Joaquim|||0000-0001-8077-3641
  • Feliu-Soler, Albert|||0000-0003-2810-7670
  • Huguet Miguel, Anna|||0000-0002-1763-5542
Introduction: Attention Deficit Hyperactivity Disorder (ADHD) has a global mean prevalence of 5%. Cognitive Training (CT) and Mindfulness-Based Interventions (MBIs) have shown promising results in managing ADHD symptoms, but they are not its Treatment-As-Usual (TAU). The NeuroMind Study aims to evaluate the preliminary effectiveness and feasibility of three interventions: Mindfulness for Health (M4H), CT using the NeuronUP® platform (CT), and a combination of both, Mindfulness Cognitive Training (MCT). There is empirical evidence supporting the effectiveness of the M4H and NeuronUP® platform; however, this study explores for the first time the effectiveness of MCT and CT, as well as the integration of M4H into TAU. The objectives of this 5-month Randomized Controlled Trial (RCT) are: (1) To analyze the preliminary effectiveness and feasibility of M4H, CT or a combination of both (MCT) added to TAU for children with ADHD; (2) To evaluate the role of psychological process variables (mindfulness and emotional regulation) as mediators of 5-month follow-up clinical outcomes; (3) To preliminarily explore whether specific sociodemographic and clinical characteristics can predict the short-and medium-term clinical response to the specific treatments. Methods and analysis: Participants will be 120 children (7 to 12 years) with ADHD recruited at Child and Adolescent Mental Health Service (CAMHS) Sant Joan de Déu Terres de Lleida (Spain) randomly allocated to one of the four study arms: TAU vs. TAU + CT vs. TAU + M4H vs. TAU + MCT. An assessment to collect ADHD symptoms, Executive Functions (EF), comorbid symptoms and global functioning will be conducted pre-intervention, post-intervention (2 months after baseline) and at the 5-month follow-up. Linear mixed models and mediational models will be computed. Discussion: If the preliminary effectiveness and feasibility of the MCT are demonstrated, this study could be a preliminary basis to do a full RCT with a larger sample to definitively validate the intervention. The MCT could be applied in clinical practice if it is definitively validated. Clinical trial registration:ClinicalTrials.gov, identifier, NCT05937347. https://clinicaltrials.gov/study/NCT05937347?locStr=Spain&country=Spain&cond=ADHD&intr=Mindfulness&rank=1.